Pyridine derivatives useful as glucokinase activators

摘要

Disclosed are compounds selected from the group, by way of example (5-bromo-pyridine-2-yl)-(4-methyl-thiazole-2-yl)-amine, (4-bromomethyl-thiazole-2-yl)-(5-bromo-pyridine-2-yl)- amine and (5-bromo-pyridine-2-yl)-(4-imidazole-1-ylmethylthiazole-2-yl)-amine for the treatment of insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus, obesity, neuropathy and/or nephropathy.